Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AGILON (NYSE: AGL) SHAREHOLDER ALERT: Kaplan Fox Investigates Potential Securities Fraud at Agilon Health, Inc. By: NewMediaWire January 26, 2024 at 10:56 AM EST NEW YORK, NY - (NewMediaWire) - January 26, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Agilon Health, Inc. (“Agilon”) (NYSE: AGL). Click Here to Join Investigation.If you acquired Agilon securities and would like to discuss our investigation, please click here or contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.On January 5, 2024, Agilon announced revised guidance expectations for 2023 due to higher medical and non-medical costs. Among other things, Agilon’s “revised 2023 medical margin expectation was revised to $340 million to $360 million, approximately $110 million below the previous guidance range” due to “90 million in higher-than-expected medical costs, as well as $20 million of negative revenue revision with two regional health plans in new geographies.” The Company also announced that its CFO would step down in 2024.Following this news, Agilon's stock price fell $3.45 per share, or 28.56%, to close at $8.63 per share on January 5, 2024.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. If you have any questions about this investigation, please contact:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003E-mail: pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
AGILON (NYSE: AGL) SHAREHOLDER ALERT: Kaplan Fox Investigates Potential Securities Fraud at Agilon Health, Inc. By: NewMediaWire January 26, 2024 at 10:56 AM EST NEW YORK, NY - (NewMediaWire) - January 26, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Agilon Health, Inc. (“Agilon”) (NYSE: AGL). Click Here to Join Investigation.If you acquired Agilon securities and would like to discuss our investigation, please click here or contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.On January 5, 2024, Agilon announced revised guidance expectations for 2023 due to higher medical and non-medical costs. Among other things, Agilon’s “revised 2023 medical margin expectation was revised to $340 million to $360 million, approximately $110 million below the previous guidance range” due to “90 million in higher-than-expected medical costs, as well as $20 million of negative revenue revision with two regional health plans in new geographies.” The Company also announced that its CFO would step down in 2024.Following this news, Agilon's stock price fell $3.45 per share, or 28.56%, to close at $8.63 per share on January 5, 2024.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. If you have any questions about this investigation, please contact:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003E-mail: pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com
NEW YORK, NY - (NewMediaWire) - January 26, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Agilon Health, Inc. (“Agilon”) (NYSE: AGL). Click Here to Join Investigation.If you acquired Agilon securities and would like to discuss our investigation, please click here or contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.On January 5, 2024, Agilon announced revised guidance expectations for 2023 due to higher medical and non-medical costs. Among other things, Agilon’s “revised 2023 medical margin expectation was revised to $340 million to $360 million, approximately $110 million below the previous guidance range” due to “90 million in higher-than-expected medical costs, as well as $20 million of negative revenue revision with two regional health plans in new geographies.” The Company also announced that its CFO would step down in 2024.Following this news, Agilon's stock price fell $3.45 per share, or 28.56%, to close at $8.63 per share on January 5, 2024.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. If you have any questions about this investigation, please contact:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003E-mail: pmayer@kaplanfox.comLaurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com
